The influence of endothelium on the neurogenic component of ouabain-induced contractions in isolated perfused guinea pig carotid arteries was analyzed. Ouabain (0.1 fimo\/L to 0.1 mmol/L) evoked concentration-dependent increases of perfusion pressure. Phentolamine (0.3 to 10 /tmol/L) and prazosin (30 nmol/L to 10 /unol/L) (nonselective antagonist of o-adrenergic receptors and selective antagonist of a,-adrenergic receptors, respectively) induced a concentration-dependent relaxation in segments precontracted with ouabain (0.1 mmol/L). When the arteries were preincubated with those blockers (both at 3 /imol/L) or the animals were pretreated with reserpine, the contractions to the glycoside were diminished, indicating that they are partially mediated by norepinephrine release from adrenergic nerve endings. Deendothelialization abolished the effect of adrenergic blockade on ouabain-induced contractions. On the other hand, deendothelialization did not modify significantly the effect of the adrenergic blockade on norepinephrine-induced contractions. The nitric oxide blocker oxyhemoglobin, at concentrations (10 /xmol/L) that abolished endothelium-dependent relaxations induced by 3 junol/L acetylcholine, or the cyclooxygenase blocker indomethacin (10 /imol/L) did not modify the relaxation caused by phentolamine. In bioassay experiments, 30 /imol/L phentolamine induced a relaxation on the ouabainelicited contraction only when the glycoside was added through a donor segment with endothelium. Ouabain-induced tritiated norepinephrine release was significantly reduced by the removal of endothelium but not by 1 fimolfL oxyhemoglobin or 1 fimo\fL indomethacin. These results suggest that the endothelium modulates the neurogenic component involved in contractions evoked by the glycoside by a diffusible factor (or factors) whose nature is unknown; however, the factor is neither nitric oxide nor a cyclooxygenase-related compound. '-5 Recently, ouabain has been proposed to be the endogenous sodium pump inhibitor associated with certain forms of hypertension.6 It is well known that ouabain may cause vasoconstriction by acting directly on the Na + ,K + -ATPase in vascular smooth muscle (myogenic component) or by releasing norepinephrine from the perivascular sympathetic nerve endings (neurogenic component). The predominant component depends on the animal and the kind of vessels studied. 711 In addition, ouabain can interfere with endothelium-dependent relaxations in several species, including humans, by means of interference with the endothelium-derived hyperpolarizing factor (EDHF), nitric oxide (NO) release, or NO effector mechanisms.
1216In previous works, we have reported that the endothelium modulates the vasoactive responses elicited by sodium pump blockade by reducing the myogenic component of the ouabain-induced contractions.1718 This effect is clearly observed in human placental vessels, which lack autonomic innervation 17 ; but in guinea pig carotid arteries it becomes evident only after the blockade of adrenergi...